Upadacitinib is an oral JAK inhibitor that reduces excessive immune activity and inflammation. It is prescribed for selected inflammatory conditions affecting the joints, skin or bowel when other treatments are unsuitable or have not provided adequate control.
| Generic Name | Upadacitinib |
| Strength | 30 mg |
| Manufacturer | MSN Laboratories Private Limited |
| Packing | 30 Tablets |
| Prescribed For | Suppresses an overactive immune system to treat chronic inflammatory and autoimmune conditions |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |
Baricitinib is an oral JAK inhibitor that reduces excessive immune activity and inflammation. Depending on local approval, it may be prescribed for rheumatoid arthritis, severe alopecia areata, atopic dermatitis or selected hospitalised patients with severe COVID-19.
| Generic Name | Baricitinib |
| Strength | 4 mg |
| Manufacturer | Eli Lilly and Company |
| Packing | 7 Tablets |
| Prescribed For | Treat moderate to severe rheumatoid arthritis, severe alopecia areata, and certain hospitalized patients with COVID-19 requiring supplemental oxygen |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |
Tofajak contains Tofacitinib 5 mg, a Janus kinase (JAK) inhibitor used primarily to treat autoimmune disorders such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.
| Generic Name | Tofacitinib |
| Manufacturer | Cipla Ltd |
| Packing | 60 Tablets in 1 Bottle |
| Prescribed For | Treat specific moderate-to-severe autoimmune and inflammatory conditions |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |
